Breast cancer trial with erythropoietin terminated unexpectedly.
暂无分享，去创建一个
[1] J. Crook,et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix , 1999, Cancer.
[2] F. Watzinger,et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. , 2001, International journal of radiation oncology, biology, physics.
[3] J. Nortier,et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Piver,et al. Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect. , 1999, Gynecologic oncology.
[5] P. Vaupel,et al. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. , 1998, British Journal of Cancer.
[6] M. Puglisi,et al. Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study , 2001 .